Emile Daoud, MD
Clinical Cardiac Electrophysiology · Cincinnati, OHNPI 1124023437
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Biosense Webster, Inc. at 53.8% of the total. Reporting peaked in 2023 at $14,863 and has fallen 81.0% since, to $2,825 in 2025.
Across 154 payments — averaging $300.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$25K
- Biotronik Inc.$6K
- Medtronic$4K
- Abbott$3K
- Boston Scientific$2K
- Altathera Pharmaceuticals LLC$2K
- plus $4K from 10 others
Across 50 payments — averaging $5423.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$271K
Across 2 payments — averaging $91,815 each. An ownership or investment interest held by the physician or an immediate family member.
- Anumana, Inc.$184K
What the payments were for
- Consulting fees$25,27855%
- Speaking & faculty fees$4,80010%
- Travel & lodging$9,99322%
- Food & beverage$6,16313%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 34 | $24,890 |
| Biotronik Inc. | 15 | $5,719 |
| Medtronic(2 entities) | 28 | $4,454 |
| Abbott | 27 | $2,900 |
| Boston Scientific | 30 | $2,192 |
| Altathera Pharmaceuticals LLC | 3 | $2,137 |
| Medical Device Business Services, Inc. | 6 | $2,090 |
| Cardiva Medical, Inc. | 2 | $1,619 |
| Acutus Medical, Inc. | 1 | $102 |
| Atricure, Inc. | 1 | $39 |
| Bayer | 2 | $32 |
| Merck | 1 | $16 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $15 |
| Novartis | 1 | $15 |
| Pfizer | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$22,280
- Sotalol Hydrochloride$2,122
- Cardiva VASCADE MVP VVCS 6-12F$1,619
- AMPLATZER AMULET$916
- AVEIR$656
- AFFERA MAPPING SYSTEM$540
- ENSITE PRECISION$312
- Carto 3 System$200
- GALLANT$139
- Confirm Rx$135
- WATCHMAN Access System$123
How this compares
$46,248 in reported general payments places this provider in the 80th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $40,217 |
| XareltoRivaroxaban | 13 | $19,488 |
| SotalolSotalol Hcl | 24 | $389 |
| Amiodarone Hcl | 14 | $177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $40,21730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Cincinnati
- Alexandru CosteaCincinnati$188K
- Gaurang GandhiCincinnati$179K
- Dilesh PatelCincinnati$81K
- Marshall WinnerCincinnati$56K
- Daniel PelchovitzCincinnati$43K
- Hemal ShahCincinnati$40K
- Wai TamCincinnati$40K
- Moses WananuCincinnati$38K
- Edward SchlossCincinnati$34K
- Andrew NollCincinnati$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.